A derivative of nicotinic acid, a component of vitamin B3 (niacin) that isn’t the same ingredient as niacinamide, yet functions in nearly the same manner (Source: www.naturaldatabase.com). There is research concerning myristyl nicotinate’s ability to improve skin barrier function, mitigate signs of sun damage, and reduce the incidence of atopic dermatitis, commonly known as dry skin. What’s more, it is compatible with several prescription drugs used to treat various skin conditions and is believed to enhance their efficacy and/or minimize side effects. Myristyl nicotinate is stabilized to prevent the release of (or quick conversion to) nicotinic acid, which can cause facial flushing, particularly in those dealing with rosacea. (Sources: Journal of Pharmaceutical and Biomedical Analysis, February 2007, pages 893-899; Drug Development and Industrial Pharmacy, November 2007, pages 1,176-1182; Experimental Dermatology, November 2007, pages 927-935; and June 2007, pages 490-499). The benefits attributed to myristyl nicotinate are the same as those for niacinamide, which makes sense given their close relation.